Chimerix cell biologist Phiroze Sethna draws samples to help him begin to grow and study new cells in his anti-viral research in 2011. Chimerix’s value has plummeted from $2.5 billion last summer to $180 million last week, forcing Chimerix to shed about a quarter of its workforce – about 40 employees – in a bid to stretch its budget.
Chimerix cell biologist Phiroze Sethna draws samples to help him begin to grow and study new cells in his anti-viral research in 2011. Chimerix’s value has plummeted from $2.5 billion last summer to $180 million last week, forcing Chimerix to shed about a quarter of its workforce – about 40 employees – in a bid to stretch its budget. 2011 News & Observer File Photo - HARRY LYNCH hlynch@newsobserver.com
Chimerix cell biologist Phiroze Sethna draws samples to help him begin to grow and study new cells in his anti-viral research in 2011. Chimerix’s value has plummeted from $2.5 billion last summer to $180 million last week, forcing Chimerix to shed about a quarter of its workforce – about 40 employees – in a bid to stretch its budget. 2011 News & Observer File Photo - HARRY LYNCH hlynch@newsobserver.com

Chimerix pins hopes on smallpox antidote

July 08, 2016 5:13 PM

More Videos

  • Tesla Superchargers are coming to Raleigh. Elon Musk explains.

    Elon Musk, CEO of Tesla Inc., explains how the Tesla Supercharger, available soon in Raleigh, charges fast, extending the range of Tesla electric cars.